Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Sign in
Join now
Deborah Wexler MD, MSc

Deborah J. Wexler MD, MSc

Associate Professor of Medicine, Harvard Medical School; Chief, Diabetes Unit, Massachusetts General Hospital, Boston, Massachusetts

Dr. Deborah J. Wexler is Associate Professor of Medicine at Harvard Medical School and Chief of the Massachusetts General Hospital Diabetes Unit.

Dr. Wexler’s research focuses on clinical effectiveness in type 2 diabetes. She has led multiple National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)– and Patient-Centered Outcomes Research Institute (PCORI)– funded projects that seek to improve the health and well-being of people with diabetes. Dr Wexler is on the editorial board of Diabetes Care, is a reviewer for multiple medical journals, and is an editor of NIDDK’s Diabetes in America.

She received her medical degree from Yale University School of Medicine, New Haven, Connecticut, and completed her internship, residency, and chief residency in internal medicine and fellowship in endocrinology at Massachusetts General Hospital in Boston.

Disclosures

  • Data monitoring committees: Novo Nordisk (for trials of oral semaglutide)

Recent Contributions to PracticeUpdate:

  1. ADA Scientific Sessions 2017: Recommendations From Dr. Deborah Wexler
  2. Cost-Effectiveness of the USPSTF Recommendations for Behavioral Counseling for Adults With CV Risk Factors
  3. Artificially Sweetened Beverages, Stroke, and Dementia
  4. After Intensive Education, Insulin Pump Slightly Better Than Multiple Daily Injections in Type 1 Diabetes
  5. Diabetic Retinopathy: A Position Statement by the ADA
  6. ADA Updates for Standards of Care
  7. 2016 Top Stories in Diabetes: The EMPA-REG RENAL OUTCOMES Trial
  8. Optimized Mealtime Insulin Dosing for Fat and Protein in Type 1 Diabetes
  9. Magnitude of Weight Loss and Changes in Physical Fitness Linked With Long-Term Cardiovascular Disease Outcomes in Overweight Diabetics
  10. Mindful Self-Compassion Intervention Improves Depression, Distress, and HbA1c in People With Diabetes

Elsewhere

Recently Updated